BioSeedXL

BioSeedXL is an Israeli biotech incubator and accelerator focused on the pharmaceutical and medical application of cannabis and cannabinoids. Headquartered in Bnei Brak, the company provides a comprehensive ecosystem for early-stage startups, offering R&D support, strategic guidance, and access to clinical infrastructure. BioSeedXL operates in partnership with MOR Research Applications, the tech transfer arm of Clalit Health Services, which facilitates access to large-scale patient data and medical facilities. The incubator's portfolio includes companies such as STERO Biotechs, which develops steroid-sparing treatments, and CannaLean, focused on metabolic disorders. BioSeedXL gained prominence through the successful exit of Talent Biotechs, which was acquired by Kalytera Therapeutics for its Graft versus Host Disease program.